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Abstract
Background: Systematic reviews are increasingly used to inform health policy-making. The conflicts of interest (COI) 
of the authors of systematic reviews may bias their results and influence their conclusions. This may in turn lead to 
misguided public policies and systems level decisions. In order to mitigate the adverse impact of COI, scientific journals 
require authors to disclose their COIs. The objective of this study was to assess the frequency and different types of COI 
that authors of systematic reviews on health policy and systems research (HSPR) report. 
Methods: We conducted a cross sectional survey. We searched the Health Systems Evidence (HSE) database of McMaster 
Health Forum for systematic reviews published in 2015. We extracted information regarding the characteristics of the 
systematic reviews and the associated COI disclosures. We conducted descriptive analyses.
Results: Eighty percent of systematic reviews included authors’ COI disclosures. Of the 160 systematic reviews that 
included COI disclosures, 15% had at least one author reporting at least one type of COI. The two most frequently 
reported types of COI were individual financial COI and individual scholarly COI (11% and 4% respectively). 
Institutional COIs were less commonly reported than individual COIs (3% and 15% respectively) and non-financial 
COIs were less commonly reported than financial COIs (6% and 14% respectively). Only one systematic review reported 
the COI disclosure by editors, and none reported disclosure by peer reviewers. All COI disclosures were in the form of a 
narrative statement in the main document and none in an online document. 
Conclusion: A fifth of systematic reviews in HPSR do not include a COI disclosure statement, highlighting the need for 
journals to strengthen and/or better implement their COI disclosure policies. While only 15% of identified disclosure 
statements report any COI, it is not clear whether this indicates a low frequency of COI versus an underreporting of 
COI, or both. 
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Implications for policy makers
• Health policy and systems research (HSPR) journals should strengthen and/or better implement their conflicts of interest (COI) disclosure 
policies.
• The disclosure and management of COI may help increase the credibility and trust in systematic reviews by policy-makers. 
• Given the potential influence of COI on research, practice and policy, governments and funding agencies are called to support research in this 
field.
Implications for the public
Disclosure represents a first step in transparency that allows readers to consider whether conflicts may have influenced conduct of a review and the 
conclusions that review authors present.
Key Messages 
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Background
Health policy-makers are increasingly relying on systematic 
reviews to inform their decisions. Such reviews can provide 
policy-makers with robust evidence to clarify problems, frame 
options to address problems, and inform policy formulation 
and implementation.1-3 Policy-makers and advocacy groups 
have reported the use of systematic reviews in a variety of 
policy areas including tobacco control, traffic safety, alcohol 
control and perinatal care.4,5 
Conflict of interest (COI) is defined as “a financial or 
intellectual relationship that may impact an individual’s 
ability to approach a scientific question with an open mind.”6,7 
COIs can influence the conduct and reporting of systematic 
reviews resulting in misguided public policies and systems-
level decisions. For instance, a study evaluating 106 review 
articles found that affiliation of the review author with the 
tobacco industry to be the only factor associated with a review 
concluding that passive smoking is not harmful.8 Another 
study found that systematic reviews with financial COIs were 
five times more likely than reviews without financial COIs 
to conclude there is no positive association between sugar-
sweetened beverage consumption and obesity.9 COI may 
influence attitudes toward reviews themselves: a systematic 
survey found that opinion articles critical of the use of 
systematic reviews for policy-making are more likely to have 
industry ties than supportive articles.10
More recently, there has been increasing attention to non-
financial COIs such as personal, political, academic, ideological, 
or religious COIs.11,12 However, it remains controversial 
whether non-financial COIs can affect professional judgment, 
and whether they should be declared and managed.13,14 There 
is one small published study that provides some evidence for 
the potential impact of intellectual COI on judgment. That 
study found that authors of primary studies with significant 
results are more likely than methodologists to believe that a 
strong association exists.15
Disclosure is an important first step towards identifying, 
assessing and responding to COIs.6 We are not aware of 
any previous studies have assessed authors’ COI disclosures 
in systematic reviews of health policy and systems research 
(HPSR). Examining the extent and the type of reporting 
would inform the development of guidelines addressing COI 
specific to the health policy and systems field. The objective 
of this study was to assess the frequency and types of COI that 
authors of systematic reviews of HPSR report.
Methods
Design Overview and Definitions
We conducted a cross-sectional survey. We defined a COI 
disclosure as a statement reporting whether a COI exists or not, 
under the conflict of interest section of the review articles. We 
classified the types of COI as per the COI framework shown 
in Figure 1 and detailed in Supplementary file 1. In addition 
to the types of COI included in the framework, we have used 
the word “loogly” to label “any additional statement in the COI 
disclosure that attempts to downplay a disclosed relationship 
by suggesting that it is unrelated to COI, for example, ‘this 
relationship did not influence his prescription of the drug.’”16 
This classification was informed by a review of the literature, 
the International Committee of Medical Journal Editors 
(ICMJE) COI disclosure form and the findings from recent 
studies that assessed COIs reported by authors of clinical 
systematic reviews and randomized controlled trials.16,17
Eligibility Criteria 
We included systematic reviews on health policy or health 
systems topics published in English in 2015. We excluded 
policy briefs, overviews of systematic reviews, economic 
evaluation and costing studies, primary studies, technical 
reports, conference reports, proceedings, abstracts, editorials 
and opinion pieces.
Search Strategy
We searched the Health Systems Evidence (HSE) database 
of McMaster Health Forum for systematic reviews published 
in 2015. HSE is a comprehensive and continuously updated 
repository of overviews of systematic reviews, systematic 
reviews, systematic review protocols, evidence briefs, 
economic evaluations and costing studies, health reform 
descriptions and health system descriptions about governance, 
financial, and delivery arrangements within health systems, 
and about implementation strategies that can support change 
in health systems.18,19 HSE relies on a number of sources to 
identify systematic reviews which include Medline (OVID), 
the Cochrane Database of Systematic Reviews, Rx for Change, 
Database of Abstracts of Reviews of Effects (DARE), Cochrane 
Qualitative and Implementation Methods Group’s reference 
database and Campbell Collaboration. 
HSE process includes duplicate assessment of eligibility 
and categorization of the identified systematic reviews to 
the appropriate health systems arrangements (governance, 
financial, delivery arrangements and implementation 
strategies). Governance Arrangements cover topics related 
to Policy authority, Organizational authority, Commercial 
authority, Professional authority, and Consumer & stakeholder 
involvement. Financial arrangements include topics on 
Financing systems, Funding organizations, Remuneration 
providers, Purchasing products & services and Incentivizing 
consumers. Delivery Arrangements comprised topics on: How 
care is designed to meet consumers’ needs, By whom care is 
Figure 1. Conflicts of Interest Framework.
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provided, Where care is provided, With what supports is care 
provided. Implementation Strategies cover three main topics: 
Consumer-targeted strategy, Provider-targeted strategy and 
Organization-targeted strategy.
We applied the HSE search filters to select the following 
categories: “systematic reviews of effects” and “systematic 
reviews addressing other questions.” Supplementary file 2 
presents the detailed search strategy.
Study Selection and Data Extraction 
Using an online sequence generator (http://www.random.
org/sequences), we drew a random sample of 200 citations 
from the citations captured by the search. We collected and 
managed study data using Research Electronic Data Capture 
(REDCap) tool hosted at the American University of Beirut. 
REDCap is a secure, web-based application designed to 
support data capture for research studies.20
We developed and pilot-tested a standardized data extraction 
form with detailed instructions. Data extractors completed 
calibration exercises and extracted data in duplicate 
and independently. They compared results and resolved 
disagreements through discussion, or with the help of a third 
reviewer if needed.
We extracted information on the general characteristics of the 
paper:
•	 Number of systematic review authors;
•	 Affiliations of the first and last authors (private or 
public academic institution, government, not-for-profit 
organization, private-for-profit, intergovernmental);
•	 Country of affiliation of the first author and its 
classification according to the World Bank list of 
economies issued in July 2015;
•	 Health policy and systems arrangements (governance, 
financial, delivery arrangements, and implementation 
strategies).
We extracted information on the characteristics of the COI 
disclosures:
•	 Form of COI disclosures (a narrative statement, an online 
document);
•	 Whether COI disclosures are made available upon 
request;
•	 Number of authors per paper who report at least one type 
of COI;
•	 Number of authors per paper who report each type and 
subtype of COI (see Figure 1 and Supplementary file 1);
•	 Characteristics of the COI (source, monetary value, 
duration);
•	 Number of authors with the same or discrepant disclosures 
between the main documents and the disclosures in the 
forms (whether published online or made available by 
authors upon our request);
•	 Whether individuals other than the authors provided 
COI disclosures (editors, peer reviewers, external writers, 
others).
We extracted information about the following characteristics 
of the journal:
•	 Impact factor
•	 Existence of a COI disclosure policy.
Data Analysis
Our descriptive analyses addressed the reviews’ general 
characteristics, and the characteristics of the COI disclosures 
and provided summary data for categorical variables as 
frequencies and percentages. For continuous variables, 
application of the Kolmogorov-Smirnov (K–S) test 
demonstrated that the distribution of the majority of the 
types of COI variables was not normal. We therefore present 
summary data for each type of COI in a tabular format as 
follows:
•	 The percentage of systematic reviews with at least 
one author disclosing the specific type of COI; the 
denominator excludes reviews that did not include a COI 
disclosure statement;
•	 For each review, we calculated the percentage of 
systematic review authors reporting a specific type of 
COI; the denominator excludes reviews with no author 
reporting at least one type of COI. Then, we calculated 
the median and interquartile range (IQR) of these 
percentages across reviews.
Results
Of the 571 systematic reviews identified by the search strategy, 
the 200 systematic reviews identified through random 
sampling were published in 152 journals.
General Characteristics of the Included Systematic Reviews
Table 1 presents the general characteristics of the included 
systematic reviews. The majority addressed the topic of 
delivery arrangements (91%) and was conducted by authors 
affiliated with institutions located in high-income countries 
(93%). Most of the first authors (77%) and last authors (75%) 
were affiliated with public academic institutions.
Characteristics of the Journals
The median impact factor of the 152 journals that published 
the included systematic reviews was 1.92 (IQR = 1.24-3.10). 
Ninety-five percent (144/152) of the journals had a COI 
disclosure policy.
Characteristics of the Reported Conflicts of Interest Disclosures
Eighty percent of systematic reviews (160/200) included COI 
disclosure statements of authors, all of which were provided 
narratively in the main document and none in an online form 
or “upon request.” Only one of the 160 reviews was published 
in a journal that did not have a COI policy. Of the 40 reviews 
that did not include a COI statement, 33 were published in 
journals that did have a COI policy.
Of the 160 systematic reviews that provided COI disclosure 
statements, 24 (15%) had at least one author reporting at 
least one type of COI. The two most frequently reported 
types of COI were individual financial COI and individual 
scholarly COI, 18 (11%) and 6 (4%) respectively. The median 
percentages of authors reporting individual financial and 
individual scholarly COIs were 33% and 40% respectively 
(out of all reviews with at least one author reporting that 
type of COI). The individual scholarly COIs in five reviews 
were related to ‘authorship of primary studies’ and in one 
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review to ‘involvement other than authorship in primary 
studies’ (specifically “collaborating with one of the trial 
authors”). 
Of the 160 systematic reviews that provided COI disclosure 
statements, more systematic reviews had at least one author 
reporting financial COIs (individual and/or institutional) 
compared to non-financial COIs (individual and/or 
institutional) (n = 18; 11% versus n = 11; 7%). Also, more 
systematic reviews had at least one author reporting 
individual COIs compared to institutional COIs (n = 24; 15% 
versus n = 5; 3%).
Table 2 presents the reporting by systematic review authors 
of the different types of COI. One systematic review reported 
COI by individuals other than the authors of systematic 
reviews, the editor. 
Individual Financial Conflicts of Interest
Table 3 presents the subtypes of individual financial COI in 
the 18 systematic reviews with at least one author reporting 
individual financial COI. The three most frequently reported 
subtypes were “personal fees” (n = 11; 61%), grant from 
source different from funding source (n =  6; 33%), and grant 
from source same as funding source (n = 5; 28%). The median 
percentages of systematic review authors reporting these 
three subtypes were 20%, 33%, 45% respectively.
Supplementary file 3 presents the characteristics of the 
reported individual financial COI of systematic reviews. Of 
the 18 systematic reviews with at least one author reporting 
individual financial COI, 16 reported the source of financial 
COI, only one of which specified the relationship of the source 
to the field under study. In that case, the source produced a 
product not the subject of the review but in the same field. 
Three reviews reported on the timing of the conflict as during 
the conduct of the study. None of the reviews reported on the 
monetary value of the financial COI. 
Discussion
Summary of Findings
In summary, four of five HPSR systematic reviews included 
a COI disclosure statement. Only 15% of systematic reviews 
including a disclosure had at least one author reporting at 
least one type of COI. The two most frequently reported types 
of COI were individual financial COI and individual scholarly 
COI (Table 2). Institutional COIs were less commonly 
reported than individual COIs while non-financial COIs were 
less commonly reported than financial COIs (Table 2).
Table 1. General Characteristics of the Included Systematic Reviews 
(N = 200)
 Overall
Number of systematic reviewers, median (IQR) 5 (3-7)
Classification of the country of the institution to which the 
first author is affiliated, No. (%)
High income 185 (93)
Upper middle income 8 (4)
Lower middle income 5 (3)
Low income 2 (1)
Affiliation of first authora
Public academic institution 153 (77)
Private academic institution 25 (13)
Government 22 (11)
Not-for-profit organization 13 (7)
Private-for-profit 5 (3)
Intergovernmental 0 (0)
Affiliation of last authora
Public academic institution 150 (75)
Government 26 (13)
Private academic institution 23 (12)
Not-for-profit organization 17 (9)
Private-for-profit 3 (2)
Intergovernmental 1 (1)
Type of Health Systems Arrangementa
Delivery arrangement 181 (91)
Implementation strategies 119 (60)
Governance arrangement 37 (19)
Financial arrangement 17 (9)
Abbreviation: IQR, interquartile range.
a Systematic reviews may have more than one option that applies.
Table 2. Reporting by Systematic Reviews Authors of the Different Types 
of Conflicts of Interest (N = 160)
 
Systematic Reviews 
With at Least 1 
Author Reporting a 
Specific Type of COIf,
No. (%)
Distribution of the 
Percentage of Authors 
Per Systematic Review 
Reporting That Type 
of COIg, Median (IQR)
At least one type 24 (15) 40 (20–50)
Individual financial 18 (11) 33 (20–54)
Individual professional 1 (1) a
Individual scholarly 6 (4) 40 (16–45)
Individual advocatory 0 (0) N/A
Individual personal 0 (0) N/A
Institutional financial 4 (3) 15 (10–42)
Institutional professional 0 (0) N/A
Institutional scholarly 1 (1) b
Institutional advocatory 2 (1) c
“Other types”h 3 (2) d
Provided a “loogly 
statement”
1 (1) e
Abbreviations: N/A, not applicable; IQR, interquartile range.
a Authors of only 1 systematic review reported individual professional COI, 
with the percentage being 33%.
b Authors of only 1 systematic review reported institutional scholarly COI, 
with the percentage being 17%.
c Authors of only 2 systematic reviews reported institutional advocatory COI, 
with the percentages being 14% and 17%.
d Authors of only 3 systematic reviews reported “other types” of COI, with 
the percentages being 14%, 17%, and 20%.
e Authors of only 1 systematic review provided a “loogly statement,” with 
the percentage being 43%.
f One systematic review can have authors reporting more than one type of 
COI.
g Calculated using the number of papers with at least one author reporting 
the specific type of COI (ie, papers counted in the preceding column) as the 
denominator.
h “Other types” of COIs included: editorial board membership (n = 2) and 
‘relationship with government agencies’ (n = 1). We consider these as 
individual and non-financial types of COI.
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Strengths and Limitations
This study used a comprehensive COI framework including 
financial, non-financial and institutional COIs. We developed 
the framework based on a review of the literature, the ICMJE 
COI disclosure form and the findings from recent studies 
that assessed COIs reported by authors of clinical systematic 
reviews and clinical trials.16,17 One potential limitation is 
that we drew our sample from only one database, the HSE. 
However, HSE is a comprehensive and continuously updated 
database that draws its content from major sources of 
systematic reviews.18
Comparison to Similar Studies
Our findings suggest that COI disclosures statements are less 
frequently included in systematic reviews of HPSR compared 
to systematic reviews in other fields. Hakoum et al found 
97% of clinical systematic reviews and 94% of clinical trials 
to include COI disclosure statements.16,17 This less stringent 
requirements for COI disclosure in journals publishing HPSR 
systematic reviews versus those publishing clinical systematic 
reviews is reflected in the field in general: while 99% of Core 
Clinical Journals have a COI disclosure policy,21 93% of HPSR 
journals have such a policy.22 
All COI disclosures were in the form of a narrative statement 
in the main document and none in an online document. This 
reflects the absence of a standard – such as the ICMJE form for 
medical journals – COI disclosure form for journals publishing 
HPSR. Indeed, our team found that only 7% of HPSR journals 
were members of the ICMJE and 88% of journals require COI 
disclosure in a narrative statement.22
The included HPSR systematic reviews had a far lower 
frequency (15%) of authors reporting any type of COI than 
Table 3. Reporting of Systematic Reviews Authors of Different Subtypes of Individual Financial  (n = 18)
 
Systematic Reviews With at Least 1 Author 
Reporting the subtype of Individual Financial 
COIe; No. (%)
Distributions of the Percentage of Authors Per 
Systematic Review Reporting That Subtype of 
COIf,  Median (IQR)
Grant from source(s) same as funding source(s) 5 (28) 45 (23–63)
Grant from source(s) different from funding source(s) 6 (33) 33 (25–50)
Employment 4 (22) 24 (10–32)
Personal fees (other than Employment) 11 (61) 20 (17–33)
Non-monetary support 1 (6) a
Drug/equipment supplies 1 (6) b
Patent(s) 0 (0) N/A
Stocks, bonds, stock options, other securities 2 (11) c
“Other subtypes” 2 (11) d
Abbreviations: N/A, not applicable; IQR, interquartile range.
a Authors of only 1 systematic review reported “non-monetary support” COI, with the percentage being 14%.
b Authors of only 1 systematic review provided a “Drug/equipment supplies,” with the percentage being 17%.
c Authors of only 2 systematic review reported “Stocks, bonds, stock options, other securities” COI, with the percentage being 14% and 50%.
d Authors of only 2 systematic review reported “Other subtypes” COI, with the percentage being 25% and 20%.
e One systematic review can have authors reporting more than one type of COI.





Figure 2:  Health Policy and Systems Research systematic reviews’ reporting of conflicts of 2 
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(2%).16 One potential explanation is the higher percentage of HPSR journals (81%) asking authors 11 
to disclose their non-financial COIs compared to Core Clinical journals (57%) and Oncology 12 
journals (42%).22-24 Apparently, journals in the HPSR field are more aware of the importance of 13 
non-financial COIs. 14 
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Only one systematic review reported the COI disclosure by individuals other than the authors of 16 
systematic reviews, namely the editor. No systematic review reported the COI disclosure by the 17 
reviewers. It is possible that editors and reviewers disclosures are collected but not published. 18 
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Figure 2. Health Policy and Systems Research Systematic Reviews’ Reporting of Conflicts of Interest Characteristics Compared With Those of Clinical 
Systematic Reviews and Randomized Controlled Trials.
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clinical systematic reviews (41%) or clinical trials (57%) (See 
Figure 2).16,17 This may be a consequence of the HSPR journals’ 
lack a standard COI disclosure form making it less likely that 
authors of HPSR recognize their COIs. Another possible 
interpretation is that HPSR systematic reviews authors may 
simply have less COIs, mainly financial, than authors of trials.
Generally, more systematic reviews had at least one author 
reporting financial COIs compared to non-financial COI. 
Also, more systematic reviews had at least one author 
reporting individual COIs compared to institutional COI. 
This finding is consistent with findings in clinical systematic 
reviews and clinical trials.16,17 However, across all reviews, the 
reporting of non-financial COI in HPSR systematic reviews 
(7%) is higher than in the Core Clinical journals systematic 
reviews (2%).16 One potential explanation is the higher 
percentage of HPSR journals (81%) asking authors to disclose 
their non-financial COIs compared to Core Clinical journals 
(57%) and Oncology journals (42%).21-23 Apparently, journals 
in the HPSR field are more aware of the importance of non-
financial COIs.
Only one systematic review reported the COI disclosure by 
individuals other than the authors of systematic reviews, 
namely the editor. No systematic review reported the COI 
disclosure by the reviewers. It is possible that editors and 
reviewers disclosures are collected but not published.
The majority of included systematic reviews were conducted 
by authors affiliated with institutions in high income 
countries, a finding consistent with the small proportion of 
systematic reviews from low and middle income countries 
in general.24-27 We also found that the majority of systematic 
reviews address the delivery arrangements topic, which 
corroborates the findings of previous studies on the topics 
covered by HPSR systematic reviews.24-26
Implications for Research, Policy and Practice
Given that 20% of systematic reviews did not have COI 
disclosure statements, HPSR journals should consider 
strengthening and/or better implementing their COI 
disclosure policies. The fact that the majority of those 
reviews were published in journals with existing COI policy, 
highlights the need for journals to implement their policies. 
As a small percentage of authors report specific types of COI 
in this study, it would be important for future studies to verify 
the completeness and accuracy of authors’ disclosures and to 
investigate the existence of under-reporting in this field. It is 
also important to keep in mind that a COI disclosure does not 
necessarily imply bias, and there is a need to develop valid 
methods to better judge when a disclosed COI is likely to be 
associated with bias.
HPSR journals should recognize the importance of COI 
disclosure by reviewers and editors and improve their 
collection and reporting. Publicizing the COI disclosure 
of reviewers and editors can increase the credibility of the 
journal and the trust of the readers and mitigate any potential 
associated bias. 
The disclosure and management of COIs helps increase the 
credibility and trust in research not only by the public but 
also by policy-makers. Disclosure represents a first step in 
transparency that allows the consideration that conflicts may 
have influenced conduct of a review and the conclusions that 
review authors present
Ethical issues 
The study involves no human subjects and required no ethical approval.
Competing interests 
Authors declare that they have no competing interests. 
Authors’ contributions 
LBK, MBH, FEJ, GG, and EAA conceived and designed the study. LBK 
coordinated the study throughout. EAA had full access to all of the data in the 
study and takes responsibility for the integrity of the data and the accuracy of 
the data analysis. LBK and MBH ran the search and study selection processes. 
LBK, MZH, AMK, MAG, SB, DJH, LCL, and HER extracted the data. LBK, AMK, 
and EAA analysed and interpreted the data. LBK and EAA wrote the first draft 
of the manuscript. All authors critically revised the manuscript and approved 
the final version.
Funding
This project was funded by the American University of Beirut Faculty of 
Medicine’s Medical Practice Plan (MPP) funds. 
Authors’ affiliations
1Center for Systematic Reviews for Health Policy and Systems Research, 
American University of Beirut, Beirut, Lebanon. 2Clinical Research Institute, 
American University of Beirut Medical Center, Beirut, Lebanon. 3Department 
of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. 4Faculty 
of Health Sciences, American University of Beirut, Beirut, Lebanon. 5Faculty 
of Medicine, American University of Beirut, Beirut, Lebanon. 6Pharmaceutical 
Science Master Course, University of Sorocaba, São Paulo, Brazil. 7Department 
of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, 
Canada. 8Department of Internal Medicine, American University of Beirut, 
Beirut, Lebanon.
Supplementary files
Supplementary file 1. The types of COI.
Supplementary file 2. Search strategy.
Supplementary file 3. The characteristics of the reported individual financial COI 
of systematic reviews.
References 
1. Lavis JN. How can we support the use of systematic reviews in 
policymaking? PLoS Med. 2009;6(11):e1000141. doi:10.1371/
journal.pmed.1000141
2. Perrier L, Mrklas K, Lavis JN, Straus SE. Interventions 
encouraging the use of systematic reviews by health 
policymakers and managers: a systematic review. Implement 
Sci. 2011;6:43. doi:10.1186/1748-5908-6-43
3. Campbell DM, Redman S, Jorm L, Cooke M, Zwi AB, Rychetnik 
L. Increasing the use of evidence in health policy: practice and 
views of policy makers and researchers. Aust New Zealand 
Health Policy. 2009;6:21. doi:10.1186/1743-8462-6-21
4. Sweet M, Moynihan R. Improving Population Health: The Uses 
of Systematic Reviews; 2007.
5. Fox DM. Systematic reviews and health policy: the influence of a 
project on perinatal care since 1988. Milbank Q. 2011;89(3):425-
449. doi:10.1111/j.1468-0009.2011.00635.x
6. Lo B, Field MJ. Conflict of Interest in Medical Research, 
Education, and Practice. Washington (DC): National Academies 
Press (US); 2009. 
7. Schunemann HJ, Osborne M, Moss J, et al. An official American 
Thoracic Society Policy statement: managing conflict of 
interest in professional societies. Am J Respir Crit Care Med. 
2009;180(6):564-580. doi:10.1164/rccm.200901-0126ST
8. Barnes DE, Bero LA. Why review articles on the health 
effects of passive smoking reach different conclusions. JAMA. 
1998;279(19):1566-1570. 
9. Bes-Rastrollo M, Schulze MB, Ruiz-Canela M, Martinez-
Bou-Karroum et al
International Journal of Health Policy and Management, 2018, 7(8), 711–717 717
Gonzalez MA. Financial conflicts of interest and reporting bias 
regarding the association between sugar-sweetened beverages 
and weight gain: a systematic review of systematic reviews. 
PLoS Med. 2013;10(12):e1001578. doi:10.1371/journal.
pmed.1001578
10. Forsyth SR, Odierna DH, Krauth D, Bero LA. Conflicts of interest 
and critiques of the use of systematic reviews in policymaking: 
an analysis of opinion articles. Syst Rev. 2014;3:122. 
doi:10.1186/2046-4053-3-122
11. Viswanathan M, Carey TS, Belinson SE, et al. AHRQ Methods 
for Effective Health Care. Identifying and Managing Nonfinancial 
Conflicts of Interest for Systematic Reviews. Rockville (MD): 
Agency for Healthcare Research and Quality (US); 2013.
12. Making sense of non-financial competing interests. PLoS Med. 
2008;5(9):e199. doi:10.1371/journal.pmed.0050199
13. Bero LA, Grundy Q. Why Having a (Nonfinancial) Interest Is 
Not a Conflict of Interest. PLoS Biol. 2016;14(12):e2001221. 
doi:10.1371/journal.pbio.2001221
14. Lenzer J. When is a point of view a conflict of interest? BMJ. 
2016;355:i6194. doi:10.1136/bmj.i6194
15. Panagiotou OA, Ioannidis JP. Primary study authors of 
significant studies are more likely to believe that a strong 
association exists in a heterogeneous meta-analysis compared 
with methodologists. J Clin Epidemiol. 2012;65(7):740-747. 
doi:10.1016/j.jclinepi.2012.01.008
16. Hakoum MB, Anouti S, Al-Gibbawi M, et al. Reporting of financial 
and non-financial conflicts of interest by authors of systematic 
reviews: a methodological survey. BMJ Open. 2016;6(8):e011997. 
doi:10.1136/bmjopen-2016-011997
17. Hakoum MB, Jouni N, Abou-Jaoude EA, et al. Authors of 
clinical trials reported individual and financial conflicts of interest 
more frequently than institutional and nonfinancial ones: a 
methodological survey. J Clin Epidemiol. 2017;87:78-86. 
doi:10.1016/j.jclinepi.2017.04.002
18. Health Systems Evidence. About HSE. https://www.healthsys-
temsevidence.org/about. Published 2016.
19. Lavis JN, Wilson MG, Moat KA, et al. Developing and refining the 
methods for a ‘one-stop shop’ for research evidence about health 
systems. Health Res Policy Syst. 2015;13:10. doi:10.1186/1478-
4505-13-10
20. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. 
Research electronic data capture (REDCap)--a metadata-driven 
methodology and workflow process for providing translational 
research informatics support. J Biomed Inform. 2009;42(2):377-
381. doi:10.1016/j.jbi.2008.08.010
21. Shawwa K, Kallas R, Koujanian S, et al. Requirements of 
clinical journals for authors’ disclosure of financial and non-
financial conflicts of interest: a cross sectional study. PLoS One. 
2016;11(3):e0152301. doi:10.1371/journal.pone.0152301
22. Khamis AM, Hakoum MB, Bou-Karroum L, et al. Requirements 
of health policy and services journals for authors to disclose 
financial and non-financial conflicts of interest: a cross-sectional 
study. Health Res Policy Syst. 2017;15(1):80. doi:10.1186/
s12961-017-0244-2
23. Kesselheim AS, Lee JL, Avorn J, Servi A, Shrank WH, Choudhry 
NK. Conflict of interest in oncology publications: a survey of 
disclosure policies and statements. Cancer. 2012;118(1):188-
195. doi:10.1002/cncr.26237
24. El-Jardali F, Akl EA, Karroum LB, et al. Systematic reviews 
addressing identified health policy priorities in Eastern 
Mediterranean countries: a situational analysis. Health Res 
Policy Syst. 2014;12:48. doi:10.1186/1478-4505-12-48
25. Law T, Lavis J, Hamandi A, Cheung A, El-Jardali F. Climate 
for evidence-informed health systems: a profile of systematic 
review production in 41 low- and middle-income countries, 1996-
2008. J Health Serv Res Policy. 2012;17(1):4-10. doi:10.1258/
jhsrp.2011.010109
26. Wilson MG, Moat KA, Lavis JN. The global stock of research 
evidence relevant to health systems policymaking. Health Res 
Policy Syst. 2013;11:32. doi:10.1186/1478-4505-11-32
27. Oliver S, Bangpan M, Stansfield C, Stewart R. Capacity for 
conducting systematic reviews in low- and middle-income 
countries: a rapid appraisal. Health Res Policy Syst. 2015;13:23. 
doi:10.1186/s12961-015-0012-0
